Hematopoietic Cell Growth Factors
"Hematopoietic Cell Growth Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
These growth factors comprise a family of hematopoietic regulators with biological specificities defined by their ability to support proliferation and differentiation of blood cells of different lineages. ERYTHROPOIETIN and the COLONY-STIMULATING FACTORS belong to this family. Some of these factors have been studied and used in the treatment of chemotherapy-induced neutropenia, myelodysplastic syndromes, and bone marrow failure syndromes.
Descriptor ID |
D016298
|
MeSH Number(s) |
D12.644.276.374.410 D12.776.467.374.410 D23.529.374.410
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hematopoietic Cell Growth Factors".
Below are MeSH descriptors whose meaning is more specific than "Hematopoietic Cell Growth Factors".
This graph shows the total number of publications written about "Hematopoietic Cell Growth Factors" by people in this website by year, and whether "Hematopoietic Cell Growth Factors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 1 | 3 | 1995 | 1 | 0 | 1 | 1997 | 1 | 3 | 4 | 1999 | 1 | 1 | 2 | 2002 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hematopoietic Cell Growth Factors" by people in Profiles.
-
Rubin CM. Platelets: iron fortified? Pediatr Hematol Oncol. 2010 Sep; 27(6):419-21.
-
Mahmud DL, G-Amlak M, Deb DK, Platanias LC, Uddin S, Wickrema A. Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells. Oncogene. 2002 Feb 28; 21(10):1556-62.
-
Platanias LC, Uddin S, Bruno E, Korkmaz M, Ahmad S, Alsayed Y, Van Den Berg D, Druker BJ, Wickrema A, Hoffman R. CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors. Exp Hematol. 1999 Aug; 27(8):1315-21.
-
Sattler M, Winkler T, Verma S, Byrne CH, Shrikhande G, Salgia R, Griffin JD. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood. 1999 May 01; 93(9):2928-35.
-
Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS, Fung JJ. Chimerism after organ transplantation. Curr Opin Nephrol Hypertens. 1997 May; 6(3):292-8.
-
Sattler M, Salgia R. Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL. Cytokine Growth Factor Rev. 1997 Mar; 8(1):63-79.
-
Laport GF, Larson RA. Treatment of adult acute lymphoblastic leukemia. Semin Oncol. 1997 Feb; 24(1):70-82.
-
Bishop MR. Potential use of hematopoietic stem cells after radiation injury. Stem Cells. 1997; 15 Suppl 2:305-10.
-
Lazarus HM, Winton EF, Williams SF, Grinblatt D, Campion M, Cooper BW, Gunn H, Manfreda S, Isaacs RE. Phase I multicenter trial of interleukin 6 therapy after autologous bone marrow transplantation in advanced breast cancer. Bone Marrow Transplant. 1995 Jun; 15(6):935-42.
-
Muta K, Krantz SB, Bondurant MC, Wickrema A. Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest. 1994 Jul; 94(1):34-43.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|